Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial

Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial

In the context of suspected neonatal sepsis, early diagnosis and stratification of patients according to clinical severity is not yet effectively achieved. In this diagnostic trial, we aimed to assess the accuracy of presepsin (PSEP) for the diagnosis and early stratification of supposedly septic ne...

Full description

Bibliographic Details
Main Authors: Carlo Pietrasanta, Andrea Ronchi, Claudia Vener, Chiara Poggi, Claudia Ballerini, Lea Testa, Rosaria Maria Colombo, Elena Spada, Carlo Dani, Fabio Mosca, Lorenza Pugni
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Antibiotics
Subjects:
newborn
neonatal sepsis
septic shock
presepsin
biomarkers
inflammation
Online Access:https://www.mdpi.com/2079-6382/10/5/580

Internet

https://www.mdpi.com/2079-6382/10/5/580

Similar Items